August 2015 FDA Recall Drug by Hospira Inc.
D-0418-2015 - Defective Container

This Class II drug recall was voluntarily initiated by Hospira Inc. on August 20, 2015 for the product Drug. The FDA reported the reason for recall as defective container. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0418-2015

Reason for Recall
Defective Container: There were customer complaints of cracked and leaking glass vials.
Initiated
08-20-2015
Reported
09-23-2015
Quantity
83,320 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Ketamine Hydrochloride Injection, USP (100 mg/mL) packaged in 5 mL multi-dose glass fliptop vials, 10 vials per box, Rx only, Manufactured by: Hospira Inc., Lake Forest, IL 60045. NDC 00409-2051-05

Batch or Lot Expiration Information

Lot# s: 43406DD, Exp 7/1/2016; 44255DD, Exp 8/1/2016